ANGO
ANGIODYNAMICS INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$11.39
+1.33%Year over year
Reported trailing growth
- Revenue
- +8.2%
- EBITDA
- —
- EBIT
- +2.5%
- EPS
- -1.3%
- Free cash flow
- +112.1%
- Operating cash flow
- +147.2%
Forward estimates
Based on analyst estimates
- Revenue
- +5.1%
- EBITDA
- +187.0%
- EPS
- +64.7%
Three-year CAGR
- Revenue
- -1.9%
- EBITDA
- -65.8%
- EBIT
- +0.1%
- Net income
- -8.1%
- EPS
- -6.0%
- Free cash flow
- +103.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Aug 1, 2026